McCloskey, Eugene
Rathi, Jeetandera
Heijmans, Stephane
Blagden, Mark
Cortet, Bernard
Czerwinski, Edward
Hadji, Peyman
Payer, Juraj
Palmer, Kerry
Stad, Robert
O’Kelly, James
Papapoulos, Socrates
Funding for this research was provided by:
amgen ltd
Article History
Received: 23 July 2021
Accepted: 6 December 2021
First Online: 22 January 2022
Declarations
:
: The study has been approved by the appropriate institutional and/or national research ethics committee; and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments, or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Eugene McCloskey: grants/research support from ActiveSignal, Amgen, AR UK, AstraZeneca, Consilient Healthcare, Fresenius Kabi GSK, Hologic, I3 Innovus, Internis, IOF, Lilly, Medtronic, Merck, MRC, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Synexus, Tethys, UCB, Unilever, and Warner Chilcott. Consultant for ActiveSignal, Amgen, Consilient Healthcare, Fresenius Kabi, GSK, Synexus, and UCB. Speaking fees from Agnovos, Amgen, AstraZeneca, Consilient Healthcare, GSK, Hologic, Internis, Lilly, Pfizer, Roche, Servier, and UCB. Bernard Cortet has received fees for occasional interventions as an expert or speaker from Alexion, Amgen, Expanscience, Ferring, Lilly, Medtronic, MSD, Mylan, Novartis, Roche Diagnostics, and UCB. Edward Czerwinski has received a travelling grant from Amgen. Kerry Palmer, Robert Stad, James O’Kelly: Amgen employment and stock ownership. Socrates Papapoulos: Consulting/speaking fees: Amgen, Myovant Sciences, Qualix DoT, Radius Health, UCB. Peyman Hadji: grants/research, consultancy, and lecture fees from Amgen, AstraZeneca, Dr. Kade/Besins, Exeltis, Gedeon Richter, Hexal, Hologic, Lilly, Mylan, Novartis, Pfizer, UCB. Jeetandera Rathi, Stephane Heijmans, Mark Blagden, Juraj Payer: No disclosures.